Uric Acid Nephrolithiasis

Nephrolithiasismedium

A 58-year-old man with gout and metabolic syndrome (obesity, DM, hypertension) presents with recurrent nephrolithiasis. CT shows bilateral small stones that are RADIOLUCENT (not visible on plain X-ray). 24-hour urine: uric acid 750 mg/day (slightly elevated), pH 5.1 (persistently acidic), creatinine clearance 65 mL/min. Uric acid crystals on urinalysis. Stone composition analysis shows 100% uric acid. Which is the MOST effective single intervention to prevent recurrent uric acid stones?

  1. A.Low-purine diet alone
  2. B.Allopurinol to reduce uric acid production
  3. C.Potassium citrate for urine alkalinizationCorrect
  4. D.Febuxostat to reduce serum uric acid levels

Explanation

Uric acid nephrolithiasis is unique among stone types in that urinary pH is the DOMINANT driver of stone formation, not just uric acid concentration. Uric acid (pKa 5.35) precipitates in acid urine: at pH <5.5, uric acid is predominantly in the non-ionized form (insoluble); at pH >6.5, it converts to urate (ionized, water-soluble). The persistently acid urine (pH 5.1) is the primary pathology, caused by reduced ammonium production (obesity, DM, insulin resistance → impaired renal ammoniagenesis → net acid retained as titratable acid, acidifying urine). Alkalinization with potassium citrate (target urine pH 6.0–6.5): converts insoluble uric acid → soluble urate → prevents stone formation AND can DISSOLVE existing uric acid stones (complete dissolution possible with sustained alkalinization). This is the most effective single intervention, addressing the pH defect directly. Allopurinol/febuxostat: reduce uric acid production and uricosuria, useful adjunct if 24h uric acid >800 mg/day or recurrence despite alkalinization, but alkalinization is more effective for preventing uric acid stones. Diet: reduces uric acid load but insufficient without pH correction.

Why each option

A.
Low-purine diet: reduces uric acid production modestly; insufficient alone, pH correction is the primary intervention.
B.
Allopurinol: useful if high uric acid excretion (>800 mg/day) or as adjunct; less effective than urinary alkalinization for pH-driven uric acid stone formation.
C.
Correct. Potassium citrate (urine alkalinization to pH 6.0–6.5): converts uric acid → urate (soluble); prevents and can dissolve uric acid stones; addresses the primary pathophysiology.
D.
Febuxostat: lowers serum urate but does not address the persistently acid urine (the primary driver of uric acid stone formation in this patient).

Reference: Moe OW, Lancet 2006 (uric acid nephrolithiasis); Maalouf NM, Kidney Int 2004; AUA Nephrolithiasis Guideline 2019

This is one of 1,100 questions in the MedBoardSA nephrology bank, with timed test mode, tutor mode, and progress tracking by topic.

Practise the full bank

More Nephrolithiasis questions

Browse other topics